China Universal Asset Management Company’s IGM Biosciences IGMS Stock Holding History

China Universal Asset Management Company’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-6,975	Closed	-$7.81K	–	494
2025 Q2	$7.81K	Buy	6,975 +140	+2%	+$171	﹤0.01%	467
2025 Q1	$7.86K	Sell	6,835 -391	-5%	-$727	﹤0.01%	484
2024 Q4	$44.2K	Buy	+7,226	New	+$85.9K	﹤0.01%	454
2023 Q4	–	Sell	-837	Closed	-$6.99K	–	453
2023 Q3	$6.99K	Buy	837 +450	+116%	+$3.82K	﹤0.01%	369
2023 Q2	$3.57K	Sell	387 -8	-2%	-$90	﹤0.01%	399
2023 Q1	$5.43K	Buy	395 +99	+33%	+$2.05K	﹤0.01%	359
2022 Q4	$5.04K	Buy	296 +24	+9%	+$480	﹤0.01%	297
2022 Q3	$6K	Buy	+272	New	+$5.49K	﹤0.01%	252

Other funds holding IGMS

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

China Universal Asset Management Company's IGMS Position: Q3 2025 in Review

China Universal Asset Management Company sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 6,975 shares — an estimated $7.81K sold.

China Universal Asset Management Company first reported a position in IGMS in Q3 2022 and held it in 8 quarters. The position peaked at $44.2K in Q4 2024. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.

China Universal Asset Management Company reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
China Universal Asset Management Company sold 6,975 IGM Biosciences shares in Q3 2025, an estimated $7.81K.
China Universal Asset Management Company first reported a position in IGM Biosciences in Q3 2022 and held it in 8 quarters.
China Universal Asset Management Company's IGM Biosciences position peaked at $44.2K in Q4 2024.
1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.

Based on China Universal Asset Management Company's 13F filing for Q3 2025, filed 10 Nov 2025.